A

Alkermes plc
D

ALKS

29.075
USD
1.40
(5.04%)
Market Open
Volume
27,129
EPS
2
Div Yield
-
P/E
13
Market Cap
4,706,025,945
OverviewSignalsIdeasNews
Related Instruments
    A
    AAL
    0.120
    (0.84%)
    14.400 USD
    A
    ALGT
    1.620
    (2.13%)
    77.740 USD
    A
    ALK
    1.080
    (2.04%)
    53.960 USD
    DAL
    DAL
    -0.810
    (-1.25%)
    64.040 USD
    H
    HA
    0.690
    (3.99%)
    18.000 USD
    J
    JBLU
    -0.04000
    (-0.56%)
    7.07000 USD
    L
    LUV
    0.190
    (0.59%)
    32.605 USD
    S
    SAVE
    -0.24000
    (-18.18%)
    1.08000 USD
    U
    UAL
    0.010
    (0.01%)
    91.170 USD
    More
News

Title: Alkermes plc

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.